Peter Keeling News Today

Canaccord Genuity Group reissued their buy rating on shares of Diaceutics (LON:DXRX – Free Report) in a research report report published on Tuesday morning, MarketBeat reports. They currently have a GBX 150 ($1.91) price objective on the stock. Diaceutics Price Performance DXRX stock opened at GBX 127.50 ($1.62) on Tuesday. The firm has a 50 […]

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Adnams PLC - Southwold, Suffolk-based brewer - Following...

Plus: The US housing market is boomering.

Plans to relocate part of a flood-hit Pembrokeshire seaside village’s shingle sea defences to protect local businesses and the main A487 road have…

The founder and chief executive of Belfast-based medical technology firm Diaceutics is stepping down after nearly two decades at the helm.

Peter Keeling set to step down as chief executive from early next year

THE chief executive of Belfast-based pharmaceutical technology and solutions provider Diaceutics is standing down after 18 years at the helm.

By Michael Susin Diaceutics reported a widened pretax loss for the first half of 2023, driven by higher costs despite a revenue jump, but backed its...

The founder and chief executive of Belfast-based medical technology firm Diaceutics is stepping down after nearly two decades at the helm.

Diaceutics PLC on Tuesday reported strong revenue growth in its first half despite a widened loss, as well as strong demand from new customers despite a cautious atmosphere in the pharmaceutical...